This bill matters because tick-borne diseases are a growing public health concern across the United States, with cases of illnesses like Lyme disease, Rocky Mountain spotted fever, and anaplasmosis on the rise. If this bill becomes law, it guarantees that federal efforts to research, monitor, prevent, and treat these diseases will not expire at the end of 2025 but will continue for another five years. This means ongoing investment in understanding how these diseases spread, developing better diagnostic tools, and educating the public on prevention.

Without this reauthorization, these critical federal programs and funding for state and local health departments would lapse, potentially leading to a decrease in surveillance, research, and response capabilities. Voters should care because it directly impacts the resources available to protect public health against a significant and increasing threat, ensuring that the government continues to play a role in combating these illnesses.